Story perspectives

Trump Administration Pushes $150M for Animal Testing Alternatives

3/19/2026

Summary

Story summary

U.S. President Donald Trump’s administration is promoting approach methodologies (NAMs) to reduce animal testing, using organoids and computational models.
U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH) announced NAM initiatives, including $150 million.
FDA draft guidance urges drug developers to use NAMs, even if unvalidated, to improve drug safety and efficacy.
Officials say NAMs could cut costs and speed, though concerns about reliability and ethics persist.

1 of 1

Story summary

U.S. President Donald Trump’s administration is promoting approach methodologies (NAMs) to reduce animal testing, using organoids and computational models.
U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH) announced NAM initiatives, including $150 million.
FDA draft guidance urges drug developers to use NAMs, even if unvalidated, to improve drug safety and efficacy.
Officials say NAMs could cut costs and speed, though concerns about reliability and ethics persist.